Inhibition of CDKL3 Downregulates STAT1 Thus Suppressing Prostate Cancer Development

Researchers showed that CDKL3 was significantly upregulated in prostate cancer tissues compared with adjacent normal tissues, and was significantly positively correlated with tumor malignancy.